Healthcare & Medical Devices Global On demand · 24-48h

Global Biopreservation Market Strategic Research Report

Global Biopreservation Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Biopreservation Market
$1.28B2025
12.1%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Home-Brew Media, Pre-Formulated Media

By Application: Drug Discovery, Regenerative Medicine, Biobanking, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Thermo Fisher Scientific, Cytiva, Sigma-Aldrich(Merck), VWR International, Lonza, Biolife Solutions, STEMCELL Technologies, WAK-Chemie Medical GmbH

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 88 pages
Market size 2025
$1.28B
Billion USD
Forecast CAGR
12.1%
2025-2032
Forecast 2032
$2.8B
Projected
Regiones
5
Asia Pacific · Latin America · MEA · Europe · North America

Vista general

Scope of the Report

The global Biopreservation market size is predicted to grow from US$ 1,283 million in 2025 to US$ 2,839 million in 2032; it is expected to grow at a CAGR of 12.1% from 2026 to 2032.

Biopreservation is a technique used for the storage of cells and tissues in a hypothermic or chemical environment to preserve biological samples with sustained integrity.Biopreservation of cells, tissues, and organs is a frequently applied and required practice used to extend the stability and viability in both short-term and long-term storage of samples for research and clinical applications. This report will only include Biopreservation media, Biopreservation equipment is not covered in this report.

The biopreservation market is primarily driven by the rapid expansion of life sciences research and the growing demand in the healthcare industry. The increasing adoption of regenerative medicine, cell therapy, immunotherapy, and personalized medicine has created a strong need for long-term storage solutions to maintain the viability and functionality of cells, tissues, and biological samples. The rise of stem cell and gene therapy has further boosted demand for cryopreservation equipment, cryoprotective agents, and advanced cold storage systems among research institutions and biopharmaceutical companies. Additionally, the global development of biobanks and the standardization of sample management in clinical research are fueling market growth. The expanding vaccine and biopharmaceutical sectors, especially with the production and distribution of novel vaccines and antibody-based drugs, also rely heavily on effective preservation technologies. Furthermore, an aging population, the rising prevalence of chronic diseases, and the increasing need for efficient supply chain and distribution systems are reinforcing market demand. Overall, technological innovations in biomedical science, the growing clinical and research requirements, and the modernization of global healthcare infrastructure are the key factors driving the biopreservation market.

Global biopreservation main players include Gasrec, Future Biogas, VERBIO, Thorso Biogas, Staples,Vegetables, Nature Energy, Asia Biogas, Deqingyuan, Mengniu, Shandong Minhe, J V Energen, AltEnergo, etc., totally accounting for about 85%. North America is the largest market, with a share over 80%. As for the types of products, it can be divided into home-brew media and pre-formulated media. Home-brew media is the largest segment, holding a share over 73%. In terms of applications, it is widely used in drug discovery, regenerative medicine, biobanking and others. The most application is regenerative medicine, with a share over 50%.

This report presents a comprehensive overview of the global Biopreservation market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Home-Brew Media
  • Pre-Formulated Media

Segment by Application

  • Drug Discovery
  • Regenerative Medicine
  • Biobanking
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Biopreservation market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Drug Discovery, Regenerative Medicine, Biobanking evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Biopreservation Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 12.1%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.28B
2025
Forecast
$2.8B
2032
CAGR
12.1%
2025–2032
Regiones
5
global
Key companies
Thermo Fisher ScientificCytivaSigma-Aldrich(Merck)VWR InternationalLonzaBiolife SolutionsSTEMCELL TechnologiesWAK-Chemie Medical GmbH
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Home-Brew MediaPre-Formulated Media
By Application
Drug DiscoveryRegenerative MedicineBiobankingOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Home-Brew Media
  • 3.1.3 Pre-Formulated Media
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Drug Discovery
  • 4.1.3 Regenerative Medicine
  • 4.1.4 Biobanking
  • 4.1.5 Others
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Thermo Fisher Scientific
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Cytiva
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Sigma-Aldrich(Merck)
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 VWR International
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Lonza
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Biolife Solutions
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 STEMCELL Technologies
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 WAK-Chemie Medical GmbH
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Biopreservation market?
The global Biopreservation market is estimated at US$ 1.28 billion in 2025 (base year) and is projected to reach US$ 2.84 billion by 2032.
How fast is the Biopreservation market expected to grow?
The market is expected to grow at a CAGR of 12.1% from 2026 to 2032, expanding from US$ 1.28 billion in 2025 to US$ 2.84 billion in 2032, roughly 2.2 times its base-year value.
What does the Biopreservation market cover?
Biopreservation is a technique used for the storage of cells and tissues in a hypothermic or chemical environment to preserve biological samples with sustained integrity.Biopreservation of cells, tissues, and organs is a frequently applied and required practice used to extend the stability and viability in both short-term and long-term storage of samples for research and clinical applications. This report will only include Biopreservation media, Biopreservation equipment is not covered in this report.
What are the main segments of the Biopreservation market by type?
By type, the market is segmented into Home-Brew Media and Pre-Formulated Media.
Which applications drive demand in the Biopreservation market?
Key applications covered include Drug Discovery, Regenerative Medicine, Biobanking and Others.
Who are the key players in the Biopreservation market?
Key players profiled include Thermo Fisher Scientific, Cytiva, Sigma-Aldrich(Merck), VWR International, Lonza, Biolife Solutions, STEMCELL Technologies and WAK-Chemie Medical GmbH.
Which regions and countries are covered for Biopreservation?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Biopreservation market?
The biopreservation market is primarily driven by the rapid expansion of life sciences research and the growing demand in the healthcare industry.
Who should buy the Biopreservation market report?
The report is intended for manufacturers and solution providers, distributors and end users in Drug Discovery, Regenerative Medicine and Biobanking, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Biopreservation market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3.500,00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.